Skip to main content
Top
Published in: Diabetologia 12/2012

01-12-2012 | Short Communication

Lower prediagnostic serum 25-hydroxyvitamin D concentration is associated with higher risk of insulin-requiring diabetes: a nested case–control study

Authors: E. D. Gorham, C. F. Garland, A. A. Burgi, S. B. Mohr, K. Zeng, H. Hofflich, J. J. Kim, C. Ricordi

Published in: Diabetologia | Issue 12/2012

Login to get access

Abstract

Aims/hypothesis

Low serum 25-hydroxyvitamin D [25(OH)D] concentration may increase risk of insulin-requiring diabetes.

Methods

A nested case–control study was performed using serum collected during 2002–2008 from military service members. One thousand subjects subsequently developed insulin-requiring diabetes. A healthy control was individually matched to each case on blood-draw date (±2 days), age (±3 months), length of service (±30 days) and sex. The median elapsed time between serum collection and first diagnosis of diabetes was 1 year (range 1 month to 10 years). Statistical analysis used matched pairs and conditional logistic regression.

Results

ORs for insulin-requiring diabetes by quintile of serum 25(OH)D, from lowest to highest, were 3.5 (95% CI 2.0, 6.0), 2.5 (1.5, 4.2), 0.8 (0.4, 1.4), 1.1 (0.6, 2.8) and 1.0 (reference) (p trend <0.001). The quintiles (based on fifths using serum 25(OH)D concentration in the controls) of serum 25(OH)D in nmol/l, were <43 (median 28), 43–59 (median 52), 60–77 (median 70), 78–99 (median 88) and ≥100 (median 128).

Conclusions/interpretation

Individuals with lower serum 25(OH)D concentrations had higher risk of insulin-requiring diabetes than those with higher concentrations. A 3.5-fold lower risk was associated with a serum 25(OH)D concentration ≥60 nmol/l.
Literature
1.
go back to reference Dabelea D, Bell RA, D’Agostino RB Jr et al (2007) Incidence of diabetes in youth in the United States. JAMA 297:2716–2724PubMedCrossRef Dabelea D, Bell RA, D’Agostino RB Jr et al (2007) Incidence of diabetes in youth in the United States. JAMA 297:2716–2724PubMedCrossRef
3.
go back to reference Gorham ED, Barrett-Connor E, Highfill-McRoy RM et al (2009) Incidence of insulin-requiring diabetes in the US military. Diabetologia 52:2087–2091PubMedCrossRef Gorham ED, Barrett-Connor E, Highfill-McRoy RM et al (2009) Incidence of insulin-requiring diabetes in the US military. Diabetologia 52:2087–2091PubMedCrossRef
4.
go back to reference Soltesz G, Patterson CC, Dahlquist G (2007) Worldwide childhood type 1 diabetes incidence—what can we learn from epidemiology? Pediatr Diabetes 8(Suppl 6):6–14PubMedCrossRef Soltesz G, Patterson CC, Dahlquist G (2007) Worldwide childhood type 1 diabetes incidence—what can we learn from epidemiology? Pediatr Diabetes 8(Suppl 6):6–14PubMedCrossRef
5.
go back to reference Mohr SB, Garland CF, Gorham ED, Garland FC (2008) The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51:1391–1398PubMedCrossRef Mohr SB, Garland CF, Gorham ED, Garland FC (2008) The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51:1391–1398PubMedCrossRef
6.
go back to reference Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500–1503PubMedCrossRef Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500–1503PubMedCrossRef
7.
go back to reference The EURODIAB Substudy 2 Study Group (1999) Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 42:51–54CrossRef The EURODIAB Substudy 2 Study Group (1999) Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 42:51–54CrossRef
8.
go back to reference Borkar VV, Verma S, Devidayal, Bhalla AK (2010) Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatr Diabetes 11:345–350PubMedCrossRef Borkar VV, Verma S, Devidayal, Bhalla AK (2010) Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatr Diabetes 11:345–350PubMedCrossRef
9.
go back to reference Bener A, Alsaied A, Al-Ali M et al (2009) High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol 46:183–189PubMedCrossRef Bener A, Alsaied A, Al-Ali M et al (2009) High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol 46:183–189PubMedCrossRef
10.
go back to reference Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M (2009) Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 32:1977–1979PubMedCrossRef Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M (2009) Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 32:1977–1979PubMedCrossRef
11.
go back to reference Rubertone MV, Brundage JF (2002) The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 92:1900–1904PubMedCrossRef Rubertone MV, Brundage JF (2002) The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 92:1900–1904PubMedCrossRef
12.
go back to reference Wagner D, Hanwell HE, Vieth R (2009) An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 42:1549–1556PubMedCrossRef Wagner D, Hanwell HE, Vieth R (2009) An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 42:1549–1556PubMedCrossRef
13.
go back to reference Wasserfall CH, Atkinson MA (2006) Autoantibody markers for the diagnosis and prediction of type 1 diabetes. Autoimmun Rev 5:424–428PubMedCrossRef Wasserfall CH, Atkinson MA (2006) Autoantibody markers for the diagnosis and prediction of type 1 diabetes. Autoimmun Rev 5:424–428PubMedCrossRef
14.
go back to reference Fourlanos S, Harrison LC, Colman PG (2008) The accelerator hypothesis and increasing incidence of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 15:321–325PubMedCrossRef Fourlanos S, Harrison LC, Colman PG (2008) The accelerator hypothesis and increasing incidence of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 15:321–325PubMedCrossRef
15.
go back to reference Verbeeten KC, Elks CE, Daneman D, Ong KK (2011) Association between childhood obesity and subsequent type 1 diabetes: a systematic review and meta-analysis. Diabet Med 28:10–18PubMedCrossRef Verbeeten KC, Elks CE, Daneman D, Ong KK (2011) Association between childhood obesity and subsequent type 1 diabetes: a systematic review and meta-analysis. Diabet Med 28:10–18PubMedCrossRef
16.
go back to reference Zella JB, McCary LC, DeLuca HF (2003) Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys 417:77–80PubMedCrossRef Zella JB, McCary LC, DeLuca HF (2003) Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys 417:77–80PubMedCrossRef
17.
go back to reference Hewison M (2012) An update on vitamin D and human immunity. Clin Endocrinol 76:315–325CrossRef Hewison M (2012) An update on vitamin D and human immunity. Clin Endocrinol 76:315–325CrossRef
18.
go back to reference Hathcock JN, Shao A, Vieth R, Heaney R (2007) Risk assessment for vitamin D. Am J Clin Nutr 85:6–18PubMed Hathcock JN, Shao A, Vieth R, Heaney R (2007) Risk assessment for vitamin D. Am J Clin Nutr 85:6–18PubMed
Metadata
Title
Lower prediagnostic serum 25-hydroxyvitamin D concentration is associated with higher risk of insulin-requiring diabetes: a nested case–control study
Authors
E. D. Gorham
C. F. Garland
A. A. Burgi
S. B. Mohr
K. Zeng
H. Hofflich
J. J. Kim
C. Ricordi
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2709-8

Other articles of this Issue 12/2012

Diabetologia 12/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.